180 related articles for article (PubMed ID: 16619579)
21. [A phase I study of combination chemotherapy using TS-1 and weekly paclitaxel for advanced gastric cancer].
Fujiwara Y; Fujita J; Kan K; Tsukahara K; Takiguchi S; Miyata H; Yasuda T; Doki Y; Monden M
Gan To Kagaku Ryoho; 2006 Jan; 33(1):45-8. PubMed ID: 16410697
[TBL] [Abstract][Full Text] [Related]
22. [A phase I study of TS-1 and weekly cisplatin in patients with advanced gastric cancer].
Kondo K; Kinoshita M; Kataoka M; Shimoyama S; Yamamura K; Ohshima Y; Furuta K; Chin K; Hatsuno T; Kajikawa M; Miura K; Horisawa M
Gan To Kagaku Ryoho; 2005 May; 32(5):637-9. PubMed ID: 15918563
[TBL] [Abstract][Full Text] [Related]
23. Phase I study of combination therapy with S-1 and docetaxel (TXT) for advanced or recurrent gastric cancer.
Yoshida K; Hirabayashi N; Takiyama W; Ninomiya M; Takakura N; Sakamoto J; Nishiyama M; Toge T
Anticancer Res; 2004; 24(3b):1843-51. PubMed ID: 15274365
[TBL] [Abstract][Full Text] [Related]
24. Phase I study of the sequential administration of S-1 and cisplatin for metastatic gastric cancer.
Baba E; Fujishima H; Kusaba H; Esaki T; Ariyama H; Kato K; Tanaka R; Mitsugi K; Shibata Y; Harada M; Nakano S
Anticancer Res; 2009 May; 29(5):1727-32. PubMed ID: 19443394
[TBL] [Abstract][Full Text] [Related]
25. Phase I/II study of s-1 plus cisplatin combination chemotherapy in patients with advanced/recurrent head and neck cancer.
Fujii M; Tomita K; Nishijima W; Tsukuda M; Hasegawa Y; Ishitoya J; Yamane H; Homma A; Tomita T
Jpn J Clin Oncol; 2010 Mar; 40(3):214-21. PubMed ID: 19934112
[TBL] [Abstract][Full Text] [Related]
26. A pilot study of combination chemotherapy with S-1 and low-dose cisplatin for highly advanced gastric cancer.
Takahashi T; Saikawa Y; Yoshida M; Kitagawa Y; Otani Y; Kubota T; Kumai K; Kitajima M
Anticancer Res; 2006; 26(2B):1631-5. PubMed ID: 16619584
[TBL] [Abstract][Full Text] [Related]
27. [Pilot study of neo-adjuvant chemotherapy involving intraperitoneal administration of paclitaxel and oral S-1 for patients with T3 gastric cancer].
Tamura S; Miki H; Okada K; Yoshimura M; Uji K; Yoshida A; Suzuki R; Nakahira S; Egawa C; Nakata K; Okamura S; Sugimoto K; Takatsuka Y
Gan To Kagaku Ryoho; 2008 Nov; 35(12):2024-6. PubMed ID: 19106511
[TBL] [Abstract][Full Text] [Related]
28. [A pilot study of low-dose TS-1 and cisplatin combination chemotherapy for advanced gastric cancer].
Kamata T; Hayashi Y; Minatoya G; Michiwa Y; Onishi I; Takeda T; Koyasaki N; Kanno M
Gan To Kagaku Ryoho; 2001 Oct; 28(10):1419-22. PubMed ID: 11681250
[TBL] [Abstract][Full Text] [Related]
29. Phase I study of paclitaxel and cisplatin for patients with advanced or recurrent gastric cancer.
Nagata N; Kobayashi M; Kojima H; Kondo K; Hirabayashi N; Matsui T; Kataoka M; Takiyama W; Miyashita Y; Nakazato H; Araki K; Itoh H; Nakao A; Sakamoto J
Hepatogastroenterology; 2005; 52(66):1905-10. PubMed ID: 16334804
[TBL] [Abstract][Full Text] [Related]
30. Feasibility study of triplet combination chemotherapy of paclitaxel, cisplatin and S-1 for advanced gastric cancer.
Fujitani K; Hasegawa H; Hirao M; Kurokawa Y; Tsujinaka T
Anticancer Res; 2011 Sep; 31(9):3085-91. PubMed ID: 21868564
[TBL] [Abstract][Full Text] [Related]
31. Phase I evaluation of continuous 5-fluorouracil infusion followed by weekly paclitaxel in patients with advanced or recurrent gastric cancer.
Kondo K; Kobayashi M; Kojima H; Hirabayashi N; Kataoka M; Araki K; Matsui T; Takiyama W; Miyashita Y; Nakazato H; Nakao A; Sakamoto J
Jpn J Clin Oncol; 2005 Jun; 35(6):332-7. PubMed ID: 15961435
[TBL] [Abstract][Full Text] [Related]
32. Phase II study of a novel oral formation of 5-fluorouracil in combination with low-dose cisplatin as preoperative chemotherapy of oral squamous cell carcinoma.
Nakazawa M; Ohnishi T; Ohmae M; Chisoku H; Yui S; Iwai S; Sumi T; Fukuda Y; Kishino M; Yura Y
Int J Clin Pharmacol Res; 2005; 25(3):115-22. PubMed ID: 16366419
[TBL] [Abstract][Full Text] [Related]
33. Phase I study of combination chemotherapy consisting of paclitaxel, cisplatin, and S-1 in patients with unresectable gastric cancer (KOGC-02).
Takahashi T; Saikawa Y; Fukuda K; Funakoshi S; Kawakubo H; Takeuchi H; Takaishi H; Kitagawa Y
Anticancer Res; 2012 Dec; 32(12):5401-6. PubMed ID: 23225443
[TBL] [Abstract][Full Text] [Related]
34. A multi-center phase II study of S-1 plus paclitaxel as first-line therapy for patients with advanced or recurrent unresectable gastric cancer.
Lee JJ; Kim SY; Chung HC; Lee KH; Song HS; Kang WK; Hong YS; Choi IS; Lee YY; Woo IS; Choi JH
Cancer Chemother Pharmacol; 2009 May; 63(6):1083-90. PubMed ID: 18813927
[TBL] [Abstract][Full Text] [Related]
35. [Weekly administration of paclitaxel with a short course of premedication for advanced or recurrent gastric cancer].
Yamamoto S; Tanaka Y; Ito T; Nakai S; Morimoto Y; Kitagawa T; Kurihara Y; Nishimura J
Gan To Kagaku Ryoho; 2003 Jan; 30(1):67-71. PubMed ID: 12557707
[TBL] [Abstract][Full Text] [Related]
36. A phase II multi-center study of triple therapy with paclitaxel, S-1 and cisplatin in patients with advanced gastric cancer.
Iwase H; Shimada M; Tsuzuki T; Ina K; Sugihara M; Haruta J; Shinoda M; Kumada T; Goto H
Oncology; 2011; 80(1-2):76-83. PubMed ID: 21659786
[TBL] [Abstract][Full Text] [Related]
37. Multicenter phase II trial of S-1 plus cisplatin in patients with untreated advanced gastric or gastroesophageal junction adenocarcinoma.
Ajani JA; Lee FC; Singh DA; Haller DG; Lenz HJ; Benson AB; Yanagihara R; Phan AT; Yao JC; Strumberg D
J Clin Oncol; 2006 Feb; 24(4):663-7. PubMed ID: 16446338
[TBL] [Abstract][Full Text] [Related]
38. A phase I study of combination S-1 plus cisplatin chemotherapy with concurrent thoracic radiation for locally advanced non-small cell lung cancer.
Chikamori K; Kishino D; Takigawa N; Hotta K; Nogami N; Kamei H; Kuyama S; Gemba K; Takemoto M; Kanazawa S; Ueoka H; Segawa Y; Takata S; Tabata M; Kiura K; Tanimoto M;
Lung Cancer; 2009 Jul; 65(1):74-9. PubMed ID: 19056143
[TBL] [Abstract][Full Text] [Related]
39. [Combination chemotherapy study of biweekly paclitaxel and S-1 administration in patients with advanced gastric cancer].
Hokita S; Aikou T; Ishigami S; Miyazono F; Nakajo A; Uenosono Y; Hamanoue M; Aridome K; Natsugoe S
Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():95-8. PubMed ID: 16897981
[TBL] [Abstract][Full Text] [Related]
40. Phase I pharmacokinetic study of weekly intravenous and intraperitoneal paclitaxel combined with S-1 for advanced gastric cancer.
Ishigami H; Kitayama J; Otani K; Kamei T; Soma D; Miyato H; Yamashita H; Hidemura A; Kaisaki S; Nagawa H
Oncology; 2009; 76(5):311-4. PubMed ID: 19299904
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]